Researchers discover a potential biomarker for episodic migraine in women.
Researchers report amplified EEG can produce diagnostic results of brain waves associated with migraine and epilepsy non-invasively.
Findings suggest developing HDAC6 inhibitors could be a novel new therapeutic avenue for the treatment of migraines.
New abortion bans and restrictions could result in life-threatening consequences for women of childbearing age with epilepsy, multiple sclerosis, and migraine due to restrictions placed on their ability to access life-saving medications. Patients in states with strict abortion restrictions are reporting they are unable to access teratogenic drugs to treat their conditions, including methotrexate, as the medications can induce abortion.
According to researchers, Botulinum toxin, or Botox, injections can help to reduce the frequency of chronic migraines. Compared to those treated with a placebo, migraine suffers experienced 1.6 fewer attacks per month following Botox injections.
Study sheds new light on how migraines may occur and why those who are susceptible to migraines see improvements in symptoms as they age.
People who use cannabis to help manage the pain associated with chronic migraine are six times more likely to suffer from rebound headaches, or medication overuse headaches, than those who do not use marijuana.
Neuroimaging study reveals altered structural brain connectivity in patients with chronic and episodic migraines.
The loss of TRESK significantly increases the risk of developing headaches and may be implicated in migraines.
Researchers have identified how a mutation causes dysfunction in a protein, which inhibits neural activity and induces migraines.
Noninvasive vagus nerve stimulation (nVNS) helps improve symptoms of pain and vertigo in patients with vestibular migraines.
Migraine sufferers who embarked on two-and-a-half hours of moderate to vigorous exercise per week reported a significant decline in their migraine triggers, including stress, depression, and sleep problems.
